Comparative efficacy and safety of two insulin aspart formulations (Rapilin and NovoRapid) when combined with metformin, for patients with diabetes mellitus: a multicenter, randomized, open-label, controlled clinical trial.
Current medical research and opinion（2022）
摘要
ChiCTR20003129041.
更多查看译文
关键词
Clinical trial,NovoRapid,Rapilin,diabetes mellitus,efficacy,insulin aspart
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要